Not applicableUnknownNCT01844310What this trial is testingRaltegravir-based Antiretroviral Therapy for Resistant HIV-1 InfectionWho this might be right forAIDS/HIV PROBLEM Peking Union Medical College 300
Testing effectiveness (Phase 2)Study completedNCT00167674What this trial is testingARVs to Prevent Breastmilk HIV:Viral and Immune ResponsesWho this might be right forHIV Infections University of Washington 58
Large-scale testing (Phase 3)UnknownNCT00007436What this trial is testingThe Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected PatientsWho this might be right forHIV Infections Gilead Sciences
Not applicableStudy completedNCT01710397What this trial is testingRapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)Who this might be right forHIV Boston University 531
Testing effectiveness (Phase 2)Study completedNCT00000891What this trial is testingImmunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableActive Not RecruitingNCT05398185What this trial is testingWiseApp for Spanish Speakers Living With HIVWho this might be right forHIV InfectionsAcquired Immune Deficiency SyndromeSexually Transmitted Diseases, Viral Columbia University 241
Not applicableStudy completedNCT03512795What this trial is testingOptimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant MutationsWho this might be right forHIV-1-infection Centre Hospitalier Universitaire Dijon 71
Testing effectiveness (Phase 2)Study completedNCT00273975What this trial is testingTrial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric PatientsWho this might be right forHIV Infections Boehringer Ingelheim 123
Testing effectiveness (Phase 2)Study completedNCT00869557What this trial is testingStudy of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsWho this might be right forHIVHIV Infections Gilead Sciences 71
Not applicableActive Not RecruitingNCT05454839What this trial is testingPreferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South AfricaWho this might be right forHIV Boston University 1,098
Large-scale testing (Phase 3)Study completedNCT01196195What this trial is testingKONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)Who this might be right forAntiretroviral Therapy in HIV-1 Infected Children PENTA Foundation 173
Not applicableStudy completedNCT04297501What this trial is testingGut Microbiota Changes of HIV Patients Before and After One Year of ARTWho this might be right forHIV Infections Peking Union Medical College Hospital 50
Not applicableUnknownNCT02167425What this trial is testingStudy of Integrating Antiretroviral Therapy With Methadone Treatment for People Who Inject DrugsWho this might be right forHIVOpioid Dependence Pangaea Global AIDS Foundation 800
Testing effectiveness (Phase 2)Study completedNCT02471430What this trial is testingReducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral TherapyWho this might be right forHIV Infection Massachusetts General Hospital 17
Not applicableUnknownNCT00053404What this trial is testingImmunologic Control of Drug Resistant HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00000916What this trial is testingThe Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their BloodWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 399
Not applicableStudy completedNCT04448158What this trial is testingDynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral TherapyWho this might be right forHIV-1-infection Association de Recherche en Virologie et Dermatologie 79
Early research (Phase 1)Study completedNCT02456558What this trial is testingEvaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive SubjectsWho this might be right forAsymptomatic HIV Infection ApoPharma 30
Not applicableEnded earlyNCT05477485What this trial is testingAntiretroviral Improvement Among Medicaid EnrolleesWho this might be right forHuman Immunodeficiency Virus Virginia Commonwealth University 4
Not applicableEnded earlyNCT00193947What this trial is testingAn Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral TherapyWho this might be right forDrug Resistance University Health Network, Toronto 56